Breast cancer prognostic portfolio
AssigneeVeridex, LLC
InventorYixin Wang
Life of this patent
Estimating the term…
Abstract
A method of prognosticating metastasis in a breast cancer patient involves identifying differential modulation of each gene (relative to the expression of the same genes in a normal population) in a combination of genes selected from a group consisting of genes. Gene expression portfolios and kits for employing the method are further aspects of the invention.
Claims17
A method of prognosticating metastasis in a breast cancer patient comprising identifying differential modulation of each gene (relative to the expression of the same genes in a normal population) in a combination of genes selected from the group consisting of Seq. ID. No.70-97.
A method of prognosticating the absence of metastasis in a breast cancer patient comprising identifying a lack of differential modulation of each gene (relative to the expression of the same genes in a normal population) in a combination of genes selected from the group consisting of Seq. ID. No. 70-97.
A diagnostic portfolio comprising isolated nucleic acid sequences, their complements, or portions thereof of a combination of genes selected from the group consisting of Seq. ID. No. 70-97.
A kit for prognosticating metastasis in a breast cancer patient comprising reagents for detecting nucleic acid sequences, their compliments, or portions thereof in a combination of genes selected from the group consisting of Seq. ID. No. 70-97.
Dependencies are inferred from the claim text.